Multicenter Trial of Cryotherapy for Retinopathy of Prematurity: ophthalmological outcomes at 10 years

Autor: P. A. Mercer, Earl A. Palmer, R. E. McClead, E. Guillet, Terri L. Young, R. C. Ramsay, C. Cronin, C. C. Barr, R. A. Johnson, M. Schramm, D. Neff, S. Awner, M. T. Miller, D. L. Miller, P. Squires, M. Jaafar, Michael R. Collins, D. K. Knobloch, Michael T. Trese, J. Mattheu, F. J. Elsas, Lanning B. Kline, M M Jr Anderson, M. X. Repka, D. Witherspoon, J. G. Diamond, J. Arnwine, R. A. Saunders, M. L K McGregor, R. Spencer, A. B. Law, R. Hampton, Graham E. Quinn, P. H. Fishman, J. D. Lavoie, J. Roarty, M. J. Burke, A. D. Letson, E. M. Helveston, F. D. Ellis, W. Tasman, S. J. Menacker, C. H. Douglas, K. P. Cheng, S. P. Donahue, J. Clarkson, J. A. Kimble, J. Simon, J. C. Johnson, H. Camarda, John D. Baker, D. R. Stager, Albert W. Biglan, Michael J. Shapiro, S. Steele, R. Olsen, R. Sinatra, J. S. Davis, P. J. Droste, D. B. Schaffer, J. D. Reynolds, P. Torrisi, S. P. Kraft, K. Skuran, J. J. Kubacki, W. S. Gilbert, D. Bates, D. L. Bremer, R. M. Siatkowski, N. Santiago, R. W. Hertle, A. M. Roth, Dale L. Phelps, Edward G. Buckley, P. M. Berry, D. Plotsky, C. Gail Summers, Julia A. Haller, E. Bluestein, J. Zobal-Ratner, G. L. Rogers, R. A. Gordon, J. N. Leffler, M. C. Wilson, D. Tingley, G. K. Whittington, John A. Jones, P. Bartholomew, R. R. Fellows, B. H. Demorest, D. Mittelman, P. Manatrey, M. Daily, G. C. Brown, C. Vygantas, N. Wood, L. M. Kaufman, A. R. Pilkerton, W. Merriam

Publikováno v: Scopus-Elsevier

To evaluate outcomes at 10 years after randomization for eyes undergoing cryotherapy vs eyes serving as controls, for patients enrolled in the Multicenter Trial of Cryotherapy for Retinopathy of Prematurity (CRYO-ROP).The randomized cohort originally

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf47afe13dff034c3fdc836396725d72
https://pubmed.ncbi.nlm.nih.gov/11483089

Levodopa/carbidopa for childhood amblyopia

Autor: L E, Leguire, G L, Rogers, D L, Bremer, P D, Walson, M L, McGregor

Publikováno v: Investigative ophthalmologyvisual science. 34(11)

To evaluate the efficacy and tolerance of two low doses of levodopa/carbidopa (25/6.25 mg, 50/12.5 mg) and placebo (Tums) in 20 children with amblyopia between the ages of 4 and 14 years.A double-masked placebo-controlled randomized 8-hour study was

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::21f2b67230d835347ab9f7635593da35
https://pubmed.ncbi.nlm.nih.gov/8407216

Electro-oculogram in vitamin A deficiency associated with cystic fibrosis. Short communication

Autor: L E, Leguire, K S, Pappa, M L, McGregor, G L, Rogers, D L, Bremer

Publikováno v: Ophthalmic paediatrics and genetics. 13(3)

Electro-oculograms (EOGs) were recorded in a patient with cystic fibrosis and vitamin A deficiency before and during vitamin A supplementation (25,000 IU/day). Before vitamin A supplementation the EOG Arden light/dark ratio was 1.27. After seven mont

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::22c46724efce54eb7221d59a3c5a42a0
https://pubmed.ncbi.nlm.nih.gov/1484697

The predictability of infant visual-evoked response testing on future visual acuity

Autor: R J, Derick, L E, Leguire, G L, Rogers, D L, Bremer

Publikováno v: Annals of ophthalmology. 22(11)

We reviewed the records of 27 infants with abnormal eye examinations and visual-evoked response (VER) testing (mean age, 10.5 months) who subsequently underwent a long-term follow-up ophthalmology examination (mean duration, 41 months). The infants w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a0b64e1bab836b1d90267ea6b4156f8e
https://pubmed.ncbi.nlm.nih.gov/2264668

Cycloplegic refraction in esotropic children. Cyclopentolate versus atropine

Autor: A L, Rosenbaum, J B, Bateman, D L, Bremer, P Y, Liu

Publikováno v: Ophthalmology. 88(10)

Retinoscopy was performed on a population of predominantly white esotropic children younger than 5.5 years with cyclopentolate 1% and atropine 1.0%. Atropine 1.0% revealed +0.34 diopters more hyperopia than cyclopentolate 1.0%, when the mean differen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a4c05be058f0f1a20756dd53a50bf422
https://pubmed.ncbi.nlm.nih.gov/7335305